Immune thrombocytopenia (ITP) is the most common acquired thrombocytopenia after
chemotherapy-induced thrombocytopenia. Existing guidelines describe the management …

Autoimmune disorders are often associated with low platelet count or thrombocytopenia. In
immune-induced thrombocytopenia (IIT), a common mechanism is increased platelet …

Our objective was to update the EULAR recommendations for the management of systemic
lupus erythematosus (SLE), based on emerging new evidence. We performed a systematic …

Systemic lupus erythematosus (SLE) is a chronic autoimmune disease that predominately
affects women. It is characterised by a broad spectrum of clinical manifestations, however, its …

Thrombosis and cardiovascular complications are common manifestations of a variety of
pathological conditions, including infections and chronic inflammatory diseases. Hence …

Objectives To describe the characteristics, treatment and outcome of patients with immune
thrombocytopenia with clinical significance (ITPCS) associated with SLE. Methods This …

In recent years, the research on the pathogenesis of systemic lupus erythematosus (SLE)
has been deepened, from the level of histopathology to the cellular and molecular biology …

Infection occurs frequently in patients with systemic lupus erythematosus (SLE), and has
been a major cause of morbidity and mortality. However, no large-scale comprehensive …

Background According to criteria for the classification of Systemic Lupus Erythematosus
(SLE), thrombocytopenia is one of the disease-defining hematologic disorders. Since the …

Patients with connective tissue disease (CTD) and advanced lung disease are often
considered suboptimal candidates for lung transplantation (LTx) due to their underlying …